A research team at the Gyeongbuk Institute of Science and Technology in Daegu, South Korea used artificial intelligence and supercomputing technology to design a new generation of anti-inflammatory proteins. Animal experiments have shown that the anti-inflammatory effect of this protein is 53% higher than existing treatments, and is expected to significantly improve the treatment of various inflammatory diseases such as rheumatism, gout, and autoimmune diseases. The relevant paper was published in the “Integration of Diagnosis and Treatment” magazine.

A research team at the Gyeongbuk Institute of Science and Technology in Daegu, South Korea used artificial intelligence and supercomputing technology to design a new generation of anti-inflammatory proteins. Animal experiments have shown that the anti-inflammatory effect of this protein is 53% higher than existing treatments, and is expected to significantly improve the treatment of various inflammatory diseases such as rheumatism, gout, and autoimmune diseases. The relevant paper was published in the “Integration of Diagnosis and Treatment” magazine.